NCT05594758View on ClinicalTrials.gov

Named Patient Program for Olverembatinib (HQP1351)

AVAILABLEEXPANDED_ACCESS
Timeline

Start Date

Not specified

Interventions
DRUG

Olverembatinib

Oral Olverembatinib

Sponsors

Collaborators (1)

Tanner Pharma Group
All Listed Sponsors
collaborator

Tanner Pharma Group

OTHER

lead

Ascentage Pharma Group Inc.

INDUSTRY

NCT05594758 - Named Patient Program for Olverembatinib (HQP1351) | Biotech Hunter | Biotech Hunter